Colorectal Cancer Treatments and Studies
Colorectal Cancer Treatments and Studies is a research topic within Oncology. Science Explorer counts 37k research works in it since 1950. 13.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers represents advancements in the research and treatment of colorectal cancer, focusing on topics such as the use of cetuximab and bevacizumab, the impact of KRAS and BRAF mutations, the efficacy of chemotherapy, and the development of molecular subtypes for precision medicine. It also explores the role of EGFR inhibitors and the molecular mechanisms underlying metastatic colorectal cancer.
- Cetuximab
- KRAS Mutations
- Fluorouracil
- Metastatic Colorectal Cancer
- BRAF Mutation
- Bevacizumab
- Chemotherapy
- EGFR Inhibitors
- Molecular Subtypes
- Precision Medicine
- Research works
- 37k fractional, since 1950
- In the world top 10%
- 5.1k per year above
- Top-10% rate
- 13.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Colorectal Cancer Treatments and Studies research?
By volume, the United States and China publish the most (1.6k and 1.3k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.6k works
- 2 China 1.3k works
- 3 Japan 613 works
- 4 Italy 335 works
- 5 Germany 259 works
- 6 France 252 works
- 7 United Kingdom 242 works
- 8 Spain 236 works
- 9 India 197 works
- 10 South Korea 191 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Colorectal Cancer Treatments and Studies research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Colorectal Cancer Treatments and Studies research, followed by Memorial Sloan Kettering Cancer Center and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 92 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 44 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 43 works
- 4 Sun Yat-sen UniversityChina 39 works
- 5 National Cancer Center Hospital EastJapan 33 works
- 6 Istituti di Ricovero e Cura a Carattere ScientificoItaly 24 works
- 7 Sichuan UniversityChina 22 works
- 8 Fudan University Shanghai Cancer CenterChina 22 works
- 9 Peking UniversityChina 21 works
- 10 Cleveland ClinicUnited States 21 works
Who are the leading researchers in Colorectal Cancer Treatments and Studies?
The most-cited researchers publishing on Colorectal Cancer Treatments and Studies include Hermann Brenner.
- 1 Hermann Brenner Germany 5.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Colorectal Cancer Treatments and Studies research done?
The largest centres of Colorectal Cancer Treatments and Studies research in 2022–2025 are Beijing (China), Shanghai (China), Tokyo (Japan) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Kashiwa.
Largest cities, 2022–2025
Where it is the local speciality
- KashiwaJP · 33.5 works55×
Location quotient: how much more of its research is in Colorectal Cancer Treatments and Studies than the world average.
Where is the best place to study Colorectal Cancer Treatments and Studies?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Harbin Medical University and Kindai University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 52.6 | 16.2% | 6.8× | 43 | +51.2% |
| 2 | Harbin Medical UniversityChina | 49.8 | 18.9% | 9.1× | 12 | +42.1% |
| 3 | Kindai UniversityJapan | 48.8 | 22.5% | 9.1× | 10 | -0.6% |
| 4 | Sun Yat-sen UniversityChina | 43.7 | 14.5% | 3.8× | 39 | +77.1% |
| 5 | Sichuan UniversityChina | 42.9 | 24.3% | 2.0× | 22 | +68.2% |
| 6 | Nanjing University of Chinese MedicineChina | 42.3 | 27.3% | 5.0× | 8 | +25.2% |
| 7 | China Medical UniversityChina | 40.2 | 26.0% | 4.2× | 9 | +32.1% |
| 8 | Harvard UniversityUnited States | 34.7 | 18.9% | 2.1× | 17 | +5.5% |
| 9 | Nanjing Medical UniversityChina | 34.7 | 14.9% | 4.6× | 15 | +28.2% |
| 10 | Peking UniversityChina | 33.3 | 14.9% | 2.1× | 22 | +46.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Colorectal Cancer Treatments and Studies research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Colorectal Cancer Treatments and Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.